1 |
Marshall AE, Rushbrook SM, Voeler SL, et al. Tumor recurrence following liver transplantation for hepatocellular carcinoma: role of tumor proliferation status. Liver Transpl 2010;16:279-288.
DOI
ScienceOn
|
2 |
Yang SH, Suh KS, Lee HW, et al. A revised scoring system utilizing serum alphafetoprotein level to expand candidates for living donor liver transplantation in hepatocellular carcinoma. Surgery 2007;141:598-609.
DOI
ScienceOn
|
3 |
Perez Saborido B, Meneu JC, Moreno E, et al. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma? Am J Surg 2005;190:383-387.
DOI
ScienceOn
|
4 |
Roayaie S, Schwarts JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns of prognosis. Liver Transpl 2004:10:534-540.
DOI
ScienceOn
|
5 |
Vivarelli M, Cuccetti A, La Barba G, et al. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. Ann Surg 2008;248:857-862.
DOI
ScienceOn
|
6 |
Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007;94:78-86.
DOI
ScienceOn
|
7 |
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699.
DOI
ScienceOn
|
8 |
Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU. Liver trnasplantation for hepatocellular carcinoma in patients who do not meet Milan criteria. Dig Dis 2007;25:329-333.
DOI
ScienceOn
|
9 |
Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893-899.
DOI
ScienceOn
|
10 |
Todo S, Furukawa H. The Japanese Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451-459.
DOI
ScienceOn
|
11 |
Hwang S, Lee SG, Lee YJ, et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006;12:920-927.
DOI
ScienceOn
|
12 |
Nanashima A, Morino S, Yamaguchi H, et al. Modified CLIP using PIVKA-II for evaluating prognosis after hepatoctomy for hepatocellular carcinoma. Eur J Surg Oncol 2003;29:735-742.
DOI
ScienceOn
|
13 |
Durand F, Regimbeau JM, Belghiti J, et al. Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol 2001;35:254-258.
DOI
ScienceOn
|
14 |
Perkins JD. Seeding risk following percutaneous approach to hepatocellular carcinoma. Liver Transpl 2007;13:1603-1607.
DOI
ScienceOn
|
15 |
Han K, Tzimas GN, Barkun JS, et al. Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol 2007;21:39-45.
DOI
|
16 |
Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation. Liver Transpl 2004;10:440-447.
DOI
ScienceOn
|
17 |
Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living donor liver transplantation? -no, never. J Hepatol 2005;43:573-577.
DOI
ScienceOn
|
18 |
Marcos A, Fisher RA, Ham JM, et al. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation. Transplantation 2000;69:1375-1379.
DOI
ScienceOn
|
19 |
Drixler TA, Vogten MJ, Ritchie ED, et al. Liver regeneration is anangiogenesis-associated phenomenon. Ann Surg 2002;236:703-712.
DOI
ScienceOn
|
20 |
Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl 2005;11:1265-1272.
DOI
ScienceOn
|
21 |
Furukawa H, Shimamura T, Suzuki T, et al. Liver transplantation for hepatocellular carcinoma: the Japanese experience. J Hepatobiliary Pancreat Surg 2009 [Epub ahead of print].
|
22 |
Hwang S, Lee SG, Belghiti J. Liver transplantation for HCC: its role. Eastern and western perspectives. J Hepatobiliary Pancreat Surg 2009 (Epub ahead of print)
|
23 |
Yao FY, Ferrel L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394-1403.
DOI
ScienceOn
|
24 |
Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from waiting list. Liver Transpl 2002;8:873-883.
DOI
ScienceOn
|
25 |
Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Trasnpl 2002;8:765-774.
DOI
ScienceOn
|
26 |
Lee SG, Hwang S, Moon DB, et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008;14:935-945.
DOI
ScienceOn
|
27 |
Kwon CH, Kim DJ, Han YS, et al. HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 2007;25:313-319.
DOI
ScienceOn
|
28 |
Ito T, Takada Y, Ueda M, et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl 2007;13:1637-1644.
DOI
ScienceOn
|
29 |
Lee SG, Ahn CS, Ha TY, et al. Liver transplantation for hepatocellular carcinoma: Korean experience. J Hepatobiliary Pancreat Surg 2009 [Epub ahead of print].
|
30 |
Sugawara Y, Tamura S, Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007;25:310-312.
DOI
ScienceOn
|
31 |
Moon DB, Lee SG. Liver transplantation. Gut and liver 2009;3:145-165.
DOI
ScienceOn
|
32 |
Moon DB, Lee SG, Hwang S. Liver transplantation for hepatocellular carcinoma: single nodule with Child-Pugh class A sized less than 3 cm. Dig Dis 2007;25:320-328.
DOI
ScienceOn
|
33 |
Gondolesi GE, Roayaie S, Munoz L, et al. Adult living donor liver transplantation for patient hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg 2004;239:142-149.
DOI
ScienceOn
|
34 |
Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095-2100.
DOI
ScienceOn
|
35 |
van der Putten AB, Bijleveld CM, Slooff MJ, Wesenhagen H, Gips CH. Selection criteria and decisions in 375 patients with liver disease, considered for liver transplantation during 1977-1985. Liver 1987;7:84-90.
|
36 |
O'Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373-379.
DOI
ScienceOn
|
37 |
Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993;218:145-151.
DOI
ScienceOn
|
38 |
Wang Z, Zhou J, Fan J, et al. Sirolimus inhibits the growth and metastatic progression of hepatocellular carcinoma. J Cancer Res Clin Oncol 2009;135:715-722.
DOI
ScienceOn
|
39 |
Toso C, Meeberg GA, Bigam DL, et al. De novo sirolimusbased immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation 2007;83:1162-1168.
DOI
ScienceOn
|
40 |
Schlitt HJ, Neipp M, Weimann A, et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma aftre liver transplantation. J Clin Oncol 1999;17:324-331.
DOI
|
41 |
Kornberg A, Küpper B, Tannapfel A, et al. Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: clinical patterns and outcome variables. Eur J Surg Oncol 2010;36:275-280.
DOI
ScienceOn
|
42 |
Taketomi A, Fukuhara T, Morita K, et al. Improved results of a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation. Ann Surg Oncol 2010 [Epub ahead of print].
|
43 |
Soderdahl G, Backman L, Isoniemi H, et al. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Transpl Int 2006;19:288-294.
DOI
ScienceOn
|
44 |
Valdivieso A, Bustamante J, Gastaca M, et al. Management of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc 2010;42:660-662.
DOI
ScienceOn
|
45 |
Lee JO, Kim DY, Lim JH, et al. Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation. J Gastroenterol Hepatol 2009;24:800-805.
DOI
ScienceOn
|
46 |
Vivarelli M, Cucchetti A, Piscaglia F, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 2005;11:497-503.
DOI
ScienceOn
|
47 |
Porrett PM, Peterman H, Rosen M, et al. Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era. Liver Transpl 2006;12:665-673.
DOI
ScienceOn
|
48 |
Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005;11:767-775.
DOI
ScienceOn
|
49 |
Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver resection for hepatocellular carcinoma. Ann Surg 2003;238:885-893.
DOI
ScienceOn
|
50 |
Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508-519.
|
51 |
Hwang S, Lee SG, Moon DB, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007;13:741-746.
DOI
ScienceOn
|
52 |
Taketomi A, Sanefuji K, Soejima Y, et al. Impact of desgamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009;87:531-537.
DOI
ScienceOn
|
53 |
Hatano E, Ikai I, Higashi T, et al. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 2006;30:1736-1741.
DOI
ScienceOn
|
54 |
Yang SH, Suh KS, Lee HW, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 2006;12:1655-1660.
DOI
ScienceOn
|
55 |
Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 2009;1796:75-90.
|
56 |
Trotter JF, Adam R, Lo CM, Kenison J. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 2006;12:1485-1488.
DOI
ScienceOn
|
57 |
Lee JS, Chu IS, Heo J, et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004;40:667-676.
DOI
ScienceOn
|
58 |
Lubienski A. Hepatocellular carcinoma: interventional bridging to liver transplantation. Transplantation 2005;80(suppl 1):S113-S119.
DOI
|
59 |
Yao FY, Kerlan RK Jr, Hirose R, et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008;48:819-827.
DOI
ScienceOn
|
60 |
Lo CM, Fan ST, Liu CL, et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004;240:151-158.
DOI
ScienceOn
|
61 |
Marsh JW, Gray E, Ness R, Starzl TE. Complications of right lobe living donor liver transplantation. J Hepatol 2009;51:715-724.
DOI
ScienceOn
|
62 |
Bruix J, Fuster J, Llovet JM. Liver transplantation for heptocellular carcinoma: foucault pendulum versus evidence-based decision. Liver Transpl 2003;9:700-702.
DOI
ScienceOn
|
63 |
Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment for moderately and well-differentiated hepatocellular carcinoma. Ann Surg 2004;239:150-159.
DOI
ScienceOn
|